- Home
- APMD vs PTA Comparison
APMD vs PTA Comparison
Compare APMD & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APMD | PTA |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 895.5M | 942.4M |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | APMD | PTA |
|---|---|---|
| Price | $16.65 | $16.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $50.33 | N/A |
| AVG Volume (30 Days) | ★ 346.0K | 311.8K |
| Earning Date | 11-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $136.18 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.88 | $16.66 |
| 52 Week High | $35.29 | $19.92 |
Technical Indicators
Market Signals| Indicator | APMD | PTA |
|---|---|---|
| Relative Strength Index (RSI) | 44.15 | 43.48 |
| Support Level | $16.43 | $16.66 |
| Resistance Level | $19.83 | $19.53 |
| Average True Range (ATR) | 1.52 | 0.25 |
| MACD | 0.28 | 0.00 |
| Stochastic Oscillator | 46.55 | 20.11 |
Price Performance
Historical ComparisonAbout APMD Apnimed Inc. Common Stock
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its main investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.